Richette Pascal, Dumontier Marie-France, Tahiri Khadija, Widerak Magdalena, Torre Antoine, Benallaoua Mourad, Rannou François, Corvol Marie-Therese, Savouret Jean-François
INSERM UMR-747, Universite Paris Descartes, UFR Biomedicale, Paris, France.
Ann Rheum Dis. 2007 Mar;66(3):345-50. doi: 10.1136/ard.2006.059550. Epub 2006 Oct 26.
To investigate the presence and functionality of oestrogen receptor alpha (ERalpha) in interleukin (IL)1beta-treated rabbit articular chondrocytes in culture, and to determine the mechanisms of 17beta oestradiol (E2) effects on IL1beta-induced inducible nitric oxide synthase (iNOS) expression.
The presence and functionality of ERalpha were investigated by immunocytochemistry and transient expression of an E2-responsive reporter construct. iNOS expression and production were determined by transient expression of a chimeric iNOS promoter-luciferase construct and protein immunoblotting. Nitric oxide (NO) production was determined by the Griess reaction. DNA-binding activities of nuclear factor-kappaB (NF-kappaB) and activated protein 1 were determined by electrophoretic mobility shift assay (EMSA)-ELISA assays. Nuclear translocation of p65 was studied by immunocytochemistry.
ERalpha was identified in the nucleus of chondrocytes. ERalpha efficiently transactivated a transiently expressed E2-responsive construct. On IL1beta treatment, ERalpha partially diffused from its nuclear localisation into the cytoplasm and its transactivation ability was impaired. Nevertheless, E2, tamoxifen and raloxifene efficiently inhibited IL1beta-induced NO production (-34%, -31% and -36%, respectively). E2 decreased IL1beta-induced iNOS protein expression (-40%). Transient expression of an iNOS promoter construct strongly suggested that iNOS expression was inhibited at the transcriptional level, and EMSA-ELISA assays showed that E2 reduced (-60%) the IL1beta-induced p65 DNA-binding capacity. Finally, the p65 nuclear translocation induced by IL1beta was also strongly decreased by E2.
Our data support a reciprocal antagonism between oestrogens and IL1beta, ultimately resulting in the decrease of cytokine-dependent NO production through transcriptional inhibition of iNOS expression. This effect was associated with selective inhibition of p65 DNA binding and nuclear translocation.
研究雌激素受体α(ERα)在白细胞介素(IL)-1β处理的培养兔关节软骨细胞中的存在情况及其功能,并确定17β-雌二醇(E2)对IL-1β诱导的诱导型一氧化氮合酶(iNOS)表达的作用机制。
通过免疫细胞化学和E2反应性报告基因构建体的瞬时表达研究ERα的存在情况及其功能。通过嵌合iNOS启动子-荧光素酶构建体的瞬时表达和蛋白质免疫印迹法测定iNOS的表达和产生。通过Griess反应测定一氧化氮(NO)的产生。通过电泳迁移率变动分析(EMSA)-酶联免疫吸附测定法测定核因子-κB(NF-κB)和活化蛋白1的DNA结合活性。通过免疫细胞化学研究p65的核转位。
在软骨细胞核中鉴定出ERα。ERα有效地反式激活瞬时表达的E2反应性构建体。用IL-1β处理后,ERα部分从其核定位扩散到细胞质中,其反式激活能力受损。然而,E2、他莫昔芬和雷洛昔芬有效地抑制了IL-1β诱导的NO产生(分别为-34%、-31%和-36%)。E2降低了IL-1β诱导的iNOS蛋白表达(-40%)。iNOS启动子构建体的瞬时表达强烈表明iNOS表达在转录水平受到抑制,EMSA-酶联免疫吸附测定法显示E2降低了(-60%)IL-1β诱导的p65 DNA结合能力。最后,E2也强烈降低了IL-1β诱导的p65核转位。
我们的数据支持雌激素与IL-1β之间的相互拮抗作用,最终通过对iNOS表达的转录抑制导致细胞因子依赖性NO产生的减少。这种作用与对p65 DNA结合和核转位的选择性抑制有关。